Tag Archive for: CDMO

Brian Berquist, PhD, Joins Wheeler Bio as Chief Development Officer

Life Science Partner announces the newest recruit for emerging CDMO:

Wheeler Bio, a CDMO, retained Life Science Partner to recruit their Chief Development Officer to lead their process development team and accelerate their platform as a technological leader within the CDMO space. Beginning in January 2023, Brian Berquist, PhD, will lead the team in Wheeler Bio’s newstate-of-the-art Oklahoma City facility, where they have revolutionized the speed of drug discovery and democratized the innovation-to-impact process.

Brian Berquist

Berquist’s solid scientific background and ability to problem-solve in an entrepreneurial environment makes him well-suited for the R&D and innovation advancements he will undertake at Wheeler Bio.

Tom Callaway, MD, Founder of Life Science Partner

In his new role as Chief Development Officer, Berquist will oversee operations including cell line development, cell culture process development, purification development, analytical development, and formulation development. He will serve as Wheeler Bio’s scientific subject-matter expert and will lead his team in the continuous improvement of advancing the company’s R&D and technology platforms.

Prior to joining Wheeler Bio, Berquist served as the Vice President of Process Development and Analytical Sciences for iBio CDMO where he directed the process development and analytical sciences divisions for both development and characterization of proprietary products and services. Earlier in his career, Berquist served in key scientific and research roles for Caliber Biotherapeutics and Texas A&M Health Science Center.

Berquist holds a Bachelor of Science degree in Biochemistry and Molecular Biology from the University of Massachusetts, and he earned his PhD in Molecular Medicine and Molecular and Cellular Biology from the University of Maryland.

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Learn More About Chief Scientific and Technology Leader Recruitment
/0 Comments/by

Detra Glinatsis Joins Alloy Therapeutics as Vice President, Business Development and Sales

Life Science Partner announces the recruitment of Detra Glinatsis to lead Alloy Therapeutics’ enterprise sales growth within the CDMO industry.

Alloy Therapeutics retained Life Science Partner to recruit their Vice President, Business Development and Sales to manage and accelerate their growth in biologics development services. Through a community of over 100 partners and developers, Alloy seeks to democratize access to pre- competitive tools, technologies, services, and company creation capabilities that are foundational for discovering and developing therapeutic biologics.

Detra Glinatsis

Life Science Partner is pleased to announce that Detra Glinatsis, former Senior Director, Business Development from AGC Biologics with experience building and leading a sales organization, will lead Alloy Therapeutics sales team.

“As a resourceful self-starter with a talent for streamlining sales processes, Glinatsis will be an instrumental addition for supporting Alloy Therapeutics’ rapid growth within the CDMO space.”

Tom Callaway, MD, Founder of Life Science Partner

In her new role at Alloy, Glinatsis will lead a team to build out the company’s customer base and sales infrastructure. She will identify and manage strategic partnerships, alliances, and joint ventures to contribute to Alloy’s expansion within the market. Additionally, Glinatsis will have the responsibility to facilitate Alloy’s participation in industry events, creation of collateral materials, and marketing of Alloy’s position within the CDMO space.

Prior to joining Alloy, Glinatsis served in various global business development roles for CDMOs and pharmaceutical companies including AGC Biologics, Sartorius, Rentschler Biopharma, Inventiv Health and Patheon Biologics. She holds a Bachelor of Science Degree in Biology from the University of Akron.

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Learn More About Chief Executive Functions
/0 Comments/by

Roger Lias, PhD, Joins Wheeler Bio as President and Chief Operating Officer

Life Science Partner announces the recruitment of Roger Lias, PhD, to Wheeler Bio to advance their expansion as cutting-edge biologics CDMO.

Roger Lias Wheeler Bio

Wheeler Bio, a CDMO, retained Life Science Partner to recruit their President and Chief Operating Officer to accelerate their growth as an industry leader in biologics development services. With a new state-of-the-art Oklahoma City facility, Wheeler Bio has revolutionized the speed of drug discovery with their novel hub-and-spoke concept and Portable CMC® platform that fast-tracks the pathway to IND.

After a nationwide search campaign, Roger Lias, PhD, former Chief Commercial Officer of Vibalogics, was recruited by Life Science Partner to serve as Wheeler Bio’s President and Chief Operating Officer beginning in September 2022.

“Lias’ well-established credibility in the biopharma CDMO industry combined with his entrepreneurial leadership experience made him an absolute fit for growing Wheeler Bio into the global partner of choice for biological companies.”

Tom Callaway, MD, Founder of Life Science Partner

Lias will hit the ground running joining the Wheeler Bio team at the BioProcess International Conference in Boston this month, September 2022. In his new role Lias will be responsible for spearheading strategic business opportunities, alliances and joint ventures and will lead a scalable business operations team keeping Wheeler’s technology development and functions aligned with the corporate strategy as industry demand increases.

Prior to joining Wheeler Bio, Lias served as the Chief Commercial Officer for Vibalogics, a Private Equity-backed CDMO that was acquired by Recipharm AB in February, 2022.  He has an extensive track record of entrepreneurial successes including Stelis Biopharma, Avid Biosciences, Allergan, Eden Pharma, Cytovance and KBI Biopharma.

Lias holds a Bachelor of Science degree in Physiology and Biochemistry from the University of Southampton in the United Kingdom. He earned his PhD from Clare College, University Cambridge.

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Learn More About Chief Executive Functions
/0 Comments/by